Canopy Growth (CGC) Shares Outstanding (2017 - 2026)

Canopy Growth (CGC) reported Shares Outstanding (Entity) of $217.3 million for Q1 2026, up 189.95% on a YoY basis from $75.0 million in Q1 2025, and down 17.7% sequentially from $264.1 million in Q4 2025.

Canopy Growth (CGC) Shares Outstanding (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Shares Outstanding (Entity) data on file, last reported at $217.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 189.95% year-over-year to $217.3 million; the trailing twelve-month figure through Mar 2026 stood at $217.3 million (up 189.95% YoY), and the FY2026 full-year result was $217.3 million, up 189.95% from the prior year.
  • Shares Outstanding (Entity) slipped to $217.3 million in Q1 2026, from $264.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $264.1 million in Q4 2025 to a low of $31.1 million in Q1 2022.
  • A 5-year average of $89.7 million and a median of $60.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) increased 2.32% in 2022 and surged 189.95% in 2026, its largest moves.
  • Tracing CGC's Shares Outstanding (Entity) over 5 years: stood at $36.5 million in 2022, then jumped by 67.08% to $60.9 million in 2023, then jumped by 51.77% to $92.5 million in 2024, then soared by 185.65% to $264.1 million in 2025, then decreased by 17.7% to $217.3 million in 2026.
  • Business Quant data shows CGC's Shares Outstanding (Entity) at $217.3 million in Q1 2026, $264.1 million in Q4 2025, and $199.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn - 298.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 298.04 Mn
Dec 31, 2025 345.53 Mn
Sep 30, 2025 274.03 Mn
Jun 30, 2025 188.32 Mn
Mar 31, 2025 107.55 Mn
Dec 31, 2024 110.31 Mn
Sep 30, 2024 86.83 Mn
Jun 30, 2024 79.24 Mn
Mar 31, 2024 74.79 Mn
Dec 31, 2023 82.92 Mn
Sep 30, 2023 71.63 Mn
Jun 30, 2023 55.05 Mn
Mar 31, 2023 46.37 Mn
Dec 31, 2022 48.61 Mn
Sep 30, 2022 47.16 Mn
Jun 30, 2022 39.85 Mn
Mar 31, 2022 39.13 Mn
Dec 31, 2021 39.38 Mn
Sep 30, 2021 39.33 Mn
Jun 30, 2021 38.41 Mn